Prevalence and incidence of mild cognitive impairment in adults with diabetes in the United States
Primary result · Prevalence of MCIResult — go to the resultOdds ratio 1.468 95 % CI 1.337–1.611Authors' conclusion
Using a nationally representative study data in the U.S., participants with diabetes had a higher prevalence and incidence of MCI than those without diabetes. Findings show the importance of developing interventions tailored to the needs of individuals with diabetes and cognitive impairment.
Study context
- Population
- US adults in the Health and Retirement Study (1996–2018); prevalence sample 14,988 (4192 [28.0%] with diabetes), incidence sample 21,824 (1534 [28.0%] with diabetes)prevalence 14,988
- Comparison
- Diabetes vs no diabetes
- Primary endpoint
- Prevalence and incidence of mild cognitive impairment (MCI)
Methodological detailsHealth and Retirement Study (HRS), nationally representative
- HRS
- Nationally representative
Primary result
Prevalence of MCI
Odds ratio
1.468
95 % CI 1.337–1.611
P < 0.001
By group
Diabetesvs Non-diabetes
OR 1.468 (95 % CI 1.337–1.611); P < 0.001
As reported in the abstract
Further findings
%
| Outcome | Diabetes | Non-diabetes | Estimate | P value | |
|---|---|---|---|---|---|
| Incidence of MCI (newly diagnosed diabetes vs none) · mean 10-year follow-up | 42.9 | 31.6 | IRR 1.314 (95 % CI 1.213–1.424) | P < 0.001 | |
| Incidence of MCI (newly diagnosed diabetes vs none) · mean 10-year follow-up | uncontrolled HR 1.498 (95 % CI 1.405–1.597) | P < 0.001 | |||
| 0.512Ratio (log scale) |
Original publication
Prevalence and incidence of mild cognitive impairment in adults with diabetes in the United States. Diabetes Res Clin Pract. Published 25 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →